Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
At the center of the lawsuit is Teva Pharmaceutical, slated to sell a generic version of the HIV prevention pill PrEP next year.
The NAFLD/NASH medications’ page includes specific information about each of the experimental dru...
Alisporivir, a once-daily drug being developed by Novartis at the forefront of a new class of hepatitis C virus (HCV) compounds known as cyclo...
Alisporivir significantly improves sustained virologic response (SVR) rates when combined with standard pegylated interferon and ribavirin
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.